392 related articles for article (PubMed ID: 30404651)
1. GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas.
Hujber Z; Horváth G; Petővári G; Krencz I; Dankó T; Mészáros K; Rajnai H; Szoboszlai N; Leenders WPJ; Jeney A; Tretter L; Sebestyén A
J Exp Clin Cancer Res; 2018 Nov; 37(1):271. PubMed ID: 30404651
[TBL] [Abstract][Full Text] [Related]
2. Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: evidence for glial dysfunction and reduced glutamate/glutamine cycling.
Chowdhury GM; Gupta M; Gibson KM; Patel AB; Behar KL
J Neurochem; 2007 Dec; 103(5):2077-91. PubMed ID: 17854388
[TBL] [Abstract][Full Text] [Related]
3. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.
Lenting K; Khurshed M; Peeters TH; van den Heuvel CNAM; van Lith SAM; de Bitter T; Hendriks W; Span PN; Molenaar RJ; Botman D; Verrijp K; Heerschap A; Ter Laan M; Kusters B; van Ewijk A; Huynen MA; van Noorden CJF; Leenders WPJ
FASEB J; 2019 Jan; 33(1):557-571. PubMed ID: 30001166
[TBL] [Abstract][Full Text] [Related]
4. Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis.
Ludewig F; Hüser A; Fromm H; Beauclair L; Bouché N
PLoS One; 2008; 3(10):e3383. PubMed ID: 18846220
[TBL] [Abstract][Full Text] [Related]
5. A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.
El-Habr EA; Dubois LG; Burel-Vandenbos F; Bogeas A; Lipecka J; Turchi L; Lejeune FX; Coehlo PL; Yamaki T; Wittmann BM; Fareh M; Mahfoudhi E; Janin M; Narayanan A; Morvan-Dubois G; Schmitt C; Verreault M; Oliver L; Sharif A; Pallud J; Devaux B; Puget S; Korkolopoulou P; Varlet P; Ottolenghi C; Plo I; Moura-Neto V; Virolle T; Chneiweiss H; Junier MP
Acta Neuropathol; 2017 Apr; 133(4):645-660. PubMed ID: 28032215
[TBL] [Abstract][Full Text] [Related]
6. Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors.
Piperi C; Saurty-Seerunghen MS; Levidou G; Sepsa A; Trigka EA; Klonou A; Markouli M; Strepkos D; Spyropoulou A; Kanakoglou DS; Lakiotaki E; Karatrasoglou EA; Boviatsis E; El-Habr EA; Korkolopoulou P
Neurotherapeutics; 2023 Apr; 20(3):881-895. PubMed ID: 36976494
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.
Jansen EE; Struys E; Jakobs C; Hager E; Snead OC; Gibson KM
BMC Dev Biol; 2008 Nov; 8():112. PubMed ID: 19040727
[TBL] [Abstract][Full Text] [Related]
9. Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1
Brown M; Turgeon C; Rinaldo P; Roullet JB; Gibson KM
Mol Genet Metab; 2019 Dec; 128(4):397-408. PubMed ID: 31699650
[TBL] [Abstract][Full Text] [Related]
10. Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency.
Gupta M; Polinsky M; Senephansiri H; Snead OC; Jansen EE; Jakobs C; Gibson KM
Neurobiol Dis; 2004 Aug; 16(3):556-62. PubMed ID: 15262267
[TBL] [Abstract][Full Text] [Related]
11. Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase.
Gibson KM; Schor DS; Gupta M; Guerand WS; Senephansiri H; Burlingame TG; Bartels H; Hogema BM; Bottiglieri T; Froestl W; Snead OC; Grompe M; Jakobs C
J Neurochem; 2002 Apr; 81(1):71-9. PubMed ID: 12067239
[TBL] [Abstract][Full Text] [Related]
12. Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Gibson KM; Gupta M; Pearl PL; Tuchman M; Vezina LG; Snead OC; Smit LM; Jakobs C
Biol Psychiatry; 2003 Oct; 54(7):763-8. PubMed ID: 14512218
[TBL] [Abstract][Full Text] [Related]
13. Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity.
Lee HHC; Pearl PL; Rotenberg A
J Child Neurol; 2021 Nov; 36(13-14):1200-1209. PubMed ID: 33624531
[TBL] [Abstract][Full Text] [Related]
14. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF
Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784
[TBL] [Abstract][Full Text] [Related]
15. Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.
Ethofer T; Seeger U; Klose U; Erb M; Kardatzki B; Kraft E; Landwehrmeyer GB; Grodd W; Storch A
Neurology; 2004 Mar; 62(6):1016-8. PubMed ID: 15037717
[TBL] [Abstract][Full Text] [Related]
16. Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas.
Pichumani K; Mashimo T; Baek HM; Ratnakar J; Mickey B; DeBerardinis RJ; Maher EA; Bachoo RM; Malloy CR; Kovacs Z
Anal Biochem; 2015 Jul; 481():4-6. PubMed ID: 25908561
[TBL] [Abstract][Full Text] [Related]
17. Kinetic and structural characterization for cofactor preference of succinic semialdehyde dehydrogenase from Streptococcus pyogenes.
Jang EH; Park SA; Chi YM; Lee KS
Mol Cells; 2014 Oct; 37(10):719-26. PubMed ID: 25256219
[TBL] [Abstract][Full Text] [Related]
18. Catabolism of GABA, succinic semialdehyde or gamma-hydroxybutyrate through the GABA shunt impair mitochondrial substrate-level phosphorylation.
Ravasz D; Kacso G; Fodor V; Horvath K; Adam-Vizi V; Chinopoulos C
Neurochem Int; 2017 Oct; 109():41-53. PubMed ID: 28300620
[TBL] [Abstract][Full Text] [Related]
19. Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.
Pearl PL; Gibson KM; Quezado Z; Dustin I; Taylor J; Trzcinski S; Schreiber J; Forester K; Reeves-Tyer P; Liew C; Shamim S; Herscovitch P; Carson R; Butman J; Jakobs C; Theodore W
Neurology; 2009 Aug; 73(6):423-9. PubMed ID: 19667317
[TBL] [Abstract][Full Text] [Related]
20. Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment.
Subramani E; Radoul M; Najac C; Batsios G; Molloy AR; Hong D; Gillespie AM; Santos RD; Viswanath P; Costello JF; Pieper RO; Ronen SM
Cancer Res; 2020 Nov; 80(22):5098-5108. PubMed ID: 32958546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
